Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders.
暂无分享,去创建一个
H. Kokubo | H. Oki | T. Taniguchi | S. Mikami | M. Kawasaki | Izumi Nomura | Hiroki Iwashita | N. Uchiyama | N. Suzuki | I. Hoffman | Naomi Kamiguchi | H. Imada | Hua Zou | Shinji Nakamura | Kosuke Nakashima | T. Ashizawa | Shigekazu Sasaki | T. Taniguchi*